Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.

Ovral L

Generic: Ethinyl Estradiol/Levonorgestrelby Pfizer India Ltd

Buy Ovral L (Ethinyl Estradiol/Levonorgestrel) online | SafeRxPills

Select pack size

1
Free shipping over $149
Free reshipment if lost
Discreet packaging
WHO-GMP certified
Secure checkout

Similar medicines

View all
Buy Novelon (Ethinyl Estradiol/Desogestrel) online | SafeRxPills

Novelon

$16.25View
Buy Crisanta (Ethinylestradiol/Drospirenone) online | SafeRxPills

Crisanta

$16.50View
Buy Diane 35 (Cyproterone Acetate/Ethinyl Estradiol) online | SafeRxPills

Diane 35

$18.90View
Buy Dronis 20 (Drospirenone/Ethinylestradiol) online | SafeRxPills

Dronis 20

$15.00View

About Ovral L

Ovral L is a monophasic combined oral contraceptive made by Pfizer Limited in Verna, Goa, India. Every tablet in the strip is identical: 150 micrograms (0.15 mg) of levonorgestrel, a progestogen, plus 30 micrograms (0.03 mg) of ethinylestradiol, an oestrogen. This 150/30 combination is one of the longest established pill formulas; in the UK it is sold as Microgynon 30 and Rigevidon, in Canada as Min-Ovral, and in the US as generics such as Portia, Altavera, Marlissa and Kurvelo. The Indian strip holds 21 white tablets and no placebo tablets. We sell Ovral L as 42 tablets (two strips, two cycles) and 63 tablets (three strips, three cycles), from about $6 a cycle before shipping, which makes it the lowest cost pill per cycle that we stock.

Everything clinical on this page is taken from Pfizer's Indian prescribing information for Ovral L (reference LPDOVL082026, revised August 2026), the label that belongs to the strip we ship. Where the US label for Kurvelo (Lupin, the same 150/30 doses, revised May 2026) or the UK Microgynon 30 label words something differently, we say which label we are quoting. Our own advice and our own arithmetic are marked as ours. Sources are listed at the end.

Ovral L at a glance

Active ingredientsLevonorgestrel 0.15 mg and ethinylestradiol 0.03 mg in each tablet
Brand and makerOvral L, Pfizer Limited, India (Wyeth LLC trademark, Pfizer Limited the licensed user)
Uses in the Indian labelPreventing pregnancy; also painful periods (primary dysmenorrhoea), abnormal uterine bleeding and endometriosis
Regulatory statusThe 150/30 combination is licensed as a prescription medicine in the US, UK, Canada and Australia under other names. This Indian Ovral L pack is not registered with the FDA, MHRA, TGA or Health Canada
Usual dose from the labelOne tablet daily for 21 days, then a 7 day break with no tablets
Half-lifeAbout 24 hours for levonorgestrel and about 25 hours for ethinylestradiol (Indian label 5.3)
Packs42 tablets (2 strips) and 63 tablets (3 strips)
Price per tablet$0.31 (42 pack) and $0.29 (63 pack), before shipping
Delivery7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149

Price per cycle

Prices are as of November 2026; the pack selector shows the current price. A cycle means one strip of 21 tablets followed by the 7 tablet-free days.

PackPricePer tabletPer cycleShippingPer tablet with shippingPer cycle with shipping
42 tablets (2 cycles)$13$0.31$6.50$25$0.90$19.00
63 tablets (3 cycles)$18$0.29$6.00$25$0.68$14.33

On a single small order the shipping fee costs more than the tablets. The 63 pack is a little cheaper per cycle even before shipping ($6.00 against $6.50), so that difference is not about delivery. Our arithmetic for longer supplies: a year is 13 cycles. Five 63 packs give 15 cycles for $90, or $115 with shipping (about $7.67 a cycle). Eight 63 packs plus one 42 pack come to $157, which ships free and covers 26 cycles (about $6.04 a cycle). The Indian label gives a shelf life of 30 months, so check the expiry date on every strip when a large order arrives. Only order months ahead if a doctor or nurse has already checked that this pill suits you.

Compared with US, UK and Australian prices

Ovral L (ours)US generics, same doses
ExamplesOvral L, Pfizer Limited, IndiaPortia, Altavera, Marlissa, Kurvelo, Ayuna, Chateal EQ
FDA approvedNo (Indian pack)Yes
Strip21 hormone tablets, then 7 days off21 hormone tablets plus 7 inactive tablets
Cost per tablet$0.29 to $0.31 before shipping$0.12154 (brand-named generics) to $0.22773 (generically named packs), NADAC
Cost per cycle$6.00 to $6.50 before shippingAbout $3.40 to $6.38 for a 28 tablet pack at NADAC (our arithmetic)

NADAC is the National Average Drug Acquisition Cost, the average price US pharmacies pay wholesalers, published by Medicaid; the rows above have an effective date of 21 October 2026 and were still current in the 11 November 2026 file. It is not what you pay at the counter. Before shipping our cycle price is at or just above the top of that range; with shipping it is well above it. If you live in the US and have a prescription, a local generic with your insurance is very likely the cheaper and simpler option, so check that first. The original US brand, Nordette (approved in 1982), is listed by the FDA as discontinued, with a Federal Register determination that it was not withdrawn for safety or effectiveness reasons.

In the UK the NHS indicative price for Microgynon 30 (dm+d, unchanged since 2010) is 282p for 63 tablets (about 94p a cycle), and the NHS says "Contraception services are free and confidential on the NHS." In Australia several 150/30 brands are listed on the PBS (item 1394J). For most UK and Australian readers a local supply costs less than ours.

We know of no published study comparing the Indian Ovral L tablet with US or UK products. They contain the same stated doses, but that is not proof that they are interchangeable products.

Ovral L or another pill from our range

Ovral L comes in one strength only. The table compares it with the other combined pills we sell that are closest to it. Prices are before shipping, as of November 2026.

PillHormones per tabletPatternOur lowest price per cycle
Ovral L (this page)Levonorgestrel 150 mcg + ethinylestradiol 30 mcgMonophasic, 21 days$6.00
LoetteLevonorgestrel 100 mcg + ethinylestradiol 20 mcgMonophasic, 21 days$13.00
TriquilarLevonorgestrel 50 to 125 mcg + ethinylestradiol 30 to 40 mcgTriphasic, three dose steps$12.50
NovelonDesogestrel 150 mcg + ethinylestradiol 30 mcgMonophasic, 21 days$7.92

The UK Microgynon 30 label (4.4) says pills containing levonorgestrel, norgestimate or norethisterone "are associated with the lowest risk of VTE" (venous blood clots), which is one reason a levonorgestrel pill is a common first choice. Our guide to pill type and blood clot risk covers the desogestrel and drospirenone comparison. Ovral G is a different, older Pfizer India pill with norgestrel and 50 micrograms of ethinylestradiol; the Ovral L label (4.4) says women starting a combined pill for the first time "should be started on preparations containing less than 50 µg of estrogens". If you cannot take oestrogen at all, Cerazette is a progestogen-only pill. Choosing or changing a pill is a decision to make with a doctor, nurse or pharmacist.

What the Indian label covers

Section 4.1 of the Indian label lists four uses: preventing pregnancy in women who choose an oral contraceptive, treating primary dysmenorrhoea (painful periods with no underlying disease), treating abnormal uterine bleeding, and treating endometriosis. For painful periods and abnormal bleeding the dose is the same as for contraception. For endometriosis the label says "Continuous treatment with two tablets daily", which is double the contraceptive dose with no break; at that dose a 63 tablet pack lasts about 31 days (our arithmetic). Abnormal bleeding and endometriosis need a diagnosis first, so use Ovral L for them only under a doctor's care. The US Kurvelo label covers pregnancy prevention only; the UK Microgynon 30 label covers "Oral contraception and the recognised gynaecological indications for such oestrogen-progestogen combinations". For endometriosis, see our Visanne (dienogest) guide.

How to take Ovral L

The Indian label (4.2) gives this schedule:

  1. Take one tablet every day at about the same time, following the order marked on the strip.
  2. Continue for 21 days, until the strip is empty.
  3. Take nothing for the next 7 days. A withdrawal bleed usually begins 2 to 3 days after the last tablet and may still be going when the next strip is due.
  4. Begin the next strip on the day after the 7 day break, whether or not the bleed has stopped.

First strip. If you have used no hormonal contraception in the past month, the Indian label says to begin "by 5th day of menstrual cycle", counting the first day of bleeding as day 1. It does not say whether extra protection is needed. The UK Microgynon 30 label starts on day 1 and says "Contraceptive protection begins immediately"; the US Kurvelo label asks for a non-hormonal back-up for 7 days only with a Sunday start. Our advice: start on day 1 of your period if you can, and use condoms for the first 7 days if you start on day 2 to 5.

Coming from another method (Indian label 4.2):

  • Another combined pill: preferably the day after its last active tablet, and no later than the day after its usual break or inactive tablets.
  • Progestogen-only pill: stop it on any day and start Ovral L the next day.
  • Implant or hormonal coil: start on the day it is removed.
  • Injection: start on the day the next injection would be due.
  • After any progestogen-only method, use a non-hormonal back-up for the first 7 days.

After pregnancy. After a first trimester abortion you may start at once, with no back-up needed. After childbirth (if not breastfeeding) or a second trimester abortion, the Indian label says start no sooner than day 28, because clot risk is raised in the weeks after delivery, and use a back-up method for the first 7 days. If you have had sex since the birth, pregnancy must be ruled out first, or you wait for your first period. Breastfeeding: the Indian label (4.6) says combined pills are "generally not recommended until the nursing mother has completely weaned her child", because they can reduce milk and small amounts pass into the milk.

Checks. The Indian label (Precautions 1) asks for a personal and family history and an examination including blood pressure, breasts, liver, legs and pelvic organs before starting, a first follow-up 3 months later, and checks at least once a year after that. In our view a blood pressure reading and a talk about smoking, migraine and clot history are the minimum before your first strip.

Missed tablets

The Indian label (4.2) uses a 12 hour cut-off:

  • One tablet, remembered within 12 hours of the usual time: take it straight away and carry on at the usual time. The Indian label asks for no back-up in this case; the UK Microgynon 30 label says "contraceptive protection is maintained".
  • One tablet remembered more than 12 hours late, or two or more missed: take the most recent missed tablet now, even if that means two in one day, and continue as normal. Use a non-hormonal back-up "for the next 7 days".
  • If fewer than 7 tablets are left in the strip at that point: go straight on to a new strip with no 7 day break. You will probably not bleed until the end of that new strip; if no bleed comes then, pregnancy must be ruled out before you continue.

The same label then prints an alternative chart that counts tablets missed by week: two missed in week 1 or 2, take two tablets on the day you remember and two the next day, with 7 days of back-up; two missed in week 3, or three or more in a row, a day 1 starter throws away the rest of the strip and starts a new one that day. The Indian text gives no back-up instruction for that last case. The US Kurvelo label uses the same chart and adds a back-up "if the patient has sex within 7 days after missing tablets". Our advice: use the 12 hour rule above, and in any case of two or more missed tablets use condoms for 7 days. If you had unprotected sex in the days before the missed tablets, ask a pharmacist about emergency contraception today; our 7 to 14 day delivery is far too slow for that. Our missed pill guide uses a general 24 hour window; for Ovral L, the label's 12 hour figure is the one to follow.

Vomiting or diarrhoea

If you vomit or have diarrhoea within 4 hours of a tablet, the Indian label (4.2) says absorption may be incomplete and the missed tablet rules apply; for a monophasic pill like Ovral L the replacement tablet comes from a spare strip. Our two and three strip packs mean you will usually have one. The US Kurvelo label puts the window at "3 to 4 hours" and says that with prolonged vomiting or diarrhoea "additional contraceptive measures should be taken". The UK Microgynon 30 label (4.2) asks for extra non-hormonal protection during the stomach upset and for the 7 days after it.

Medicines that interact with Ovral L

Medicines that can make it fail. The Indian label (4.5) lists liver enzyme inducers: rifampicin, rifabutin, barbiturates, primidone, phenylbutazone, phenytoin, dexamethasone, griseofulvin, topiramate, some protease inhibitors and modafinil, plus St John's wort and ritonavir. It also lists anything that speeds gut transit. Use a non-hormonal back-up alongside the tablets while you take any of them. The Indian label then asks for back-up "for at least 7 days" after stopping, longer after an enzyme inducer because induction "may sometimes take several weeks" to wear off. The US Kurvelo label (Table 1) gives a firm figure: back-up "for 28 days after discontinuing the enzyme inducer", and its list adds aprepitant, bosentan, carbamazepine, efavirenz, felbamate, oxcarbazepine and rufinamide. Our advice: follow the 28 day figure. For long-term use of such medicines, the Indian label says a combined pill "should not be considered the primary contraceptive".

Colesevelam (a cholesterol medicine) lowers ethinylestradiol levels; the US label says take the two at least 4 hours apart.

Hepatitis C treatment. The Indian label (4.3, 4.5) contraindicates combined pills with ombitasvir, paritaprevir, ritonavir and dasabuvir, because of liver enzyme (ALT) rises; switch to a progestogen-only or non-hormonal method before starting, and restart Ovral L 2 weeks after the course ends. The US Kurvelo label also says not to combine it with glecaprevir/pibrentasvir.

Medicines that raise hormone levels: atorvastatin, vitamin C, paracetamol and CYP3A4 inhibitors such as indinavir and fluconazole (Indian label); the US label adds rosuvastatin, itraconazole, voriconazole, ketoconazole and grapefruit juice.

Effects on other medicines: ciclosporin, theophylline and corticosteroid levels may rise and lamotrigine levels may fall (Indian label); the US label adds that this "may reduce seizure control" and that dose adjustment "may be necessary". With flunarizine, the Indian label notes reports of galactorrhoea (milky nipple discharge). Women on thyroid hormone or cortisol replacement may need a higher dose (US label).

Antibiotics. The Indian label says there have been reports of pregnancy when combined pills were taken with "certain antibiotics (e.g., ampicillin and other penicillins, tetracyclines)". Tell the prescriber you take Ovral L whenever you start a new medicine.

Bleeding pattern and side effects

The US Kurvelo label (Warnings 9) gives bleeding figures from two trials of the 150/30 tablet, one with 1,084 women over 8,186 cycles and one with 238 women over 1,102 cycles:

Measure (share of reported cycles)Trial 1Trial 2
Breakthrough bleeding6.9%8.1%
Spotting8.6%7.9%
Any bleeding between periods13.1%12.9%
No withdrawal bleed (amenorrhoea)1.5%1.5%
Women who stopped because of bleeding3.0% (33 of 1,084)2.5% (6 of 238)

Both labels say irregular bleeding is most common in the first three months. If it persists, or starts after months of regular cycles, a doctor should look for another cause. A missed bleed: the Indian label says that if two withdrawal bleeds in a row are missed, or one is missed after tablets were not taken as directed, stop and use a non-hormonal method until pregnancy has been excluded.

Frequency in the Indian label (4.8)Selected effects
Very common (10% or more)Headache including migraine; breakthrough bleeding or spotting
Common (1% to under 10%)Nausea, vomiting, abdominal pain; breast pain or tenderness; mood changes including depression; change in libido; nervousness; dizziness; acne; vaginal thrush; fluid retention; weight change; painful periods; missed periods
Uncommon (0.1% to under 1%)Rise in blood pressure; changes in blood fats; appetite change; cramps and bloating; rash; chloasma (brown facial patches, which may persist); hair loss; excess hair growth
Rare (0.01% to under 0.1%)Anaphylactic reactions; glucose intolerance; contact lens intolerance; cholestatic jaundice; erythema nodosum; lower folate levels
Very rare (under 0.01%)Liver cancer; optic neuritis; retinal vein thrombosis; pancreatitis; ischaemic colitis; gallbladder disease; haemolytic uraemic syndrome

Mood. The Indian label (Precautions 4) says women with past depression should be watched closely and should stop if it returns "to a serious degree"; the US label tells women to contact their healthcare provider if depression occurs, "including shortly after initiating the treatment".

Cancer. The Indian label (4.4) quotes a meta-analysis of 54 studies with a relative risk of 1.24 for a breast cancer diagnosis in current users, fading over the 10 years after stopping, and a relative risk of 1.90 for invasive cervical cancer after 5 or more years of use in another meta-analysis; the label names persistent HPV infection as "the most important risk factor for cervical cancer". The newer US label (Warnings 11) says studies "have not found a consistent association" with breast cancer, with relative risks of 1.19 to 1.33 in current or recent users in two of three studies. It puts benign liver adenoma at about 3.3 cases per 100,000 users and liver cancer at under one case per million users.

Effectiveness. The Indian label (5.2) gives a failure rate of about 0.1% a year with consistent use and about 5% a year with typical use.

Blood clots, heart attack and stroke

Combined pills raise the risk of clots in veins (deep vein thrombosis, pulmonary embolism) and arteries (heart attack, stroke). These are the label figures, each attributed:

GroupVenous clotsSource
Women not on the pill5 to 10 per 100,000 women-yearsIndian Ovral L label 4.4
Users of pills with under 50 mcg ethinylestradiolAbout 20 to 40 per 100,000 women-years, varying with the progestogenIndian Ovral L label 4.4
Combined pill users3 to 9 per 10,000 woman-years (30 to 90 per 100,000; our conversion)US Kurvelo label, Warnings 1
PregnancyAbout 60 per 100,000 women-yearsIndian Ovral L label 4.4

The Indian label says the extra risk is highest in the first year a woman ever uses a combined pill and that a venous clot is fatal in 1 to 2% of cases. The US label adds that risk is also highest when restarting after a break of four weeks or more. Risk rises with obesity, increasing age, the weeks after childbirth, long immobility and surgery. If feasible, the Indian label says stop the pill four weeks before elective surgery with a raised clot risk and for two weeks after it, and during prolonged immobilisation.

Smoking. Each label words this differently:

  • US Kurvelo label, boxed warning: "Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs, including Kurvelo, are contraindicated in women who are over 35 years of age and smoke."
  • Indian Ovral L label (4.4): the risk "is quite marked in women over 35 years of age", smoking 15 or more cigarettes a day was linked with "a significantly increased risk", and "Women who use COCs should be strongly advised not to smoke."
  • UK Microgynon 30 label (4.4): "Women over 35 who continue to smoke should be strongly advised to use a different method of contraception."

Our position: if you are over 35 and smoke, do not buy Ovral L or any combined pill from us. Speak to a doctor about other methods.

Migraine and blood pressure. The Indian label (4.4) says women with migraine, particularly migraine with aura, who take combined pills "may be at increased risk of stroke". A first migraine, worse migraines, or a new headache pattern that is "recurrent, persistent or severe" means stopping the pill and having the cause checked (Indian label 4.4). If blood pressure rises significantly while on the pill, the label says stop it.

When to get urgent help

The Indian label (section 9) tells women to seek urgent medical attention for the signs below, which can point to a clot, heart attack or stroke. The US Kurvelo label (Warnings 1) says to stop the pill if a clot occurs. Calling emergency services straight away (911 in the US and Canada, 999 in the UK, 000 in Australia) is our advice:

  • pain or swelling in one leg
  • sudden severe chest pain, with or without spread to the left arm
  • sudden shortness of breath or a sudden cough
  • an unusual headache that is severe and does not go away
  • sudden loss of part or all of your sight, double vision, slurred speech, trouble finding words, or vertigo
  • collapse, with or without a seizure
  • sudden weakness or numbness on one side of the body or in one limb, or trouble moving
  • sudden severe pain in the abdomen

Also get emergency help for swelling of the lips, tongue or throat, difficulty breathing, or hives, which can be a severe allergic reaction (rare in the Indian label 4.8). See a doctor promptly for yellow skin or eyes (the US label says stop the pill if jaundice develops), sudden changes in vision or bulging eyes (Indian label 4.4: stop and have it checked at once), or low mood that is getting worse. Tell the staff that you take levonorgestrel with ethinylestradiol, the dose and since when.

Too many tablets. The Indian label (4.9) lists nausea, vomiting, breast tenderness, dizziness, abdominal pain, drowsiness or tiredness and withdrawal bleeding, with no specific antidote. The US label says there have been no reports of serious harm from overdose, "including ingestion by children". If a child swallows tablets, phone a doctor or poison line for advice (our advice).

Who should not take Ovral L

Never take it if any of these apply (Indian label 4.3, "must not be used"):

  • a deep vein thrombosis or other blood clot, now or in the past
  • disease of the blood vessels of the brain or of the heart's arteries
  • heart valve disease or a heart rhythm disorder that makes clots likely
  • an inherited or acquired clotting tendency (thrombophilia)
  • headaches with focal neurological symptoms, such as aura
  • diabetes that has affected the blood vessels
  • high blood pressure that is not controlled
  • breast cancer or another oestrogen-dependent cancer, known or suspected
  • liver adenoma or liver cancer, or active liver disease until liver tests are normal again
  • vaginal bleeding that has not been diagnosed
  • pancreatitis linked to very high triglycerides, now or in the past
  • pregnancy, known or suspected
  • allergy to levonorgestrel, ethinylestradiol or any ingredient of the tablet
  • the hepatitis C medicines named above

The US Kurvelo label also contraindicates it in women over 35 who smoke; diabetes in women over 35, diabetes with high blood pressure or organ damage, or diabetes for more than 20 years; migraine with aura at any age, or any migraine over 35; any past breast cancer; high blood pressure with blood vessel disease; and acute viral hepatitis or severe (decompensated) cirrhosis.

Not indicated: before the first period or after the menopause (Indian label 4.6).

Use with care and close monitoring (Indian label 4.4 and Precautions): high blood pressure or a past history of it (the label says another method "may be preferable"), diabetes or impaired glucose tolerance, raised blood fats (non-hormonal contraception "should be considered" if uncontrolled), past depression, cholestasis in pregnancy or with earlier pill use, and hereditary angioedema, which oestrogens may bring on or worsen. The US label adds gallbladder disease and conditions made worse by fluid retention.

Ingredients. The tablets contain lactose (Indian label 2).

Sexually transmitted infections. Ovral L does not protect against HIV or other sexually transmitted infections; the Indian label prints this at the top of page one. Condoms do.

Prescription and legal status

  • US: 150/30 levonorgestrel pills are FDA-approved generics sold on prescription (Kurvelo, for example, is listed as a prescription drug on DailyMed). The first daily pill the FDA approved for sale without a prescription, Opill (July 2023), is a progestogen-only norgestrel pill, not a combined pill. The FDA says personal importation of unapproved drugs is illegal in most circumstances.
  • UK: Microgynon 30 and the other 150/30 combined pills are prescription-only medicines (POM). The pills UK pharmacies can sell without a prescription are progestogen-only desogestrel pills such as Hana and Lovima (reclassified to pharmacy medicines in July 2021); we found no combined pill with that pharmacy (P) status. The NHS says "A pharmacist may be able to supply the combined pill for free without a prescription", meaning through an NHS service after a consultation. The Indian Ovral L pack is not authorised in the UK.
  • Canada: Min-Ovral 21 and 28 (Pfizer Canada, DIN 02042320 and 02042339) and Ovima 21 and 28 (Apotex) are listed as prescription products in Health Canada's Drug Product Database. We found no DIN for the Indian pack.
  • Australia: 150/30 pills such as Levlen ED are Schedule 4 (prescription only), and several brands are listed on the PBS (item 1394J). We found no ARTG entry for the Indian pack.
  • India: Tata 1mg and Truemeds mark Ovral L as prescription required.

Whatever the local rules, a combined pill should start after a blood pressure check and a review of your clot, migraine and smoking history by a doctor, nurse or pharmacist.

Buying genuine Ovral L

The MHRA warns that "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have", and advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". That warning applies to this Indian pack. When your order arrives, check the carton and strip: the Indian label describes white, round, flat, bevel-edged tablets with no markings, 21 to a strip in a clear PVC and printed foil blister, and the carton should name Ovral L, levonorgestrel and ethinyloestradiol tablets I.P., Pfizer, a batch number and an expiry date. These checks cannot prove the tablets are genuine, because packaging can be copied. A contraceptive that does not work gives no warning sign, so if anything about a strip looks wrong, use condoms and take a pregnancy test if a withdrawal bleed does not arrive (our advice). If a batch causes unexpected symptoms, get medical advice and report it to the MHRA Yellow Card scheme, FDA MedWatch, the TGA or Health Canada, as well as to us.

Delivery

Ovral L ships to the US, UK, Australia and Canada in plain packaging with tracking. Delivery usually takes 7 to 14 business days. Shipping is $25 on orders under $149 and free from $149. The Indian label says store below 30°C and protect from moisture; Tata 1mg and PharmEasy say below 25°C. Reorder at least three weeks before your last strip runs out, so a delay in the post never stretches your 7 day break. See our shipping page and refund policy.

Related guides

Sources

  • Pfizer Limited, India. Levonorgestrel and Ethinyloestradiol Tablets I.P., OVRAL L, prescribing information LPDOVL082026, date of revision August 2026: sections 1 to 5.3, 7, 8.2 to 8.4, 9 and 10. Pfizer labeling
  • Kurvelo (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/30 mcg), prescribing information, Lupin Pharmaceuticals, revised May 2026 (DailyMed SPL version 12): boxed warning, Indications, Contraindications, Warnings 1, 2, 3, 6, 9, 10, 11 and 12, Precautions 2, 4, 7 and 10, Overdosage, Dosage and Administration. DailyMed
  • Microgynon 30, Summary of Product Characteristics, Bayer plc, PL 00010/0545, date of revision 13 February 2023: 4.1, 4.2, 4.4. emc
  • NHS Dictionary of Medicines and Devices via OpenPrescribing: Microgynon 30 tablets, 63 tablets, POM, NHS indicative price 282p. OpenPrescribing
  • NHS. Combined pill: where to get it (last reviewed 15 February 2024). NHS
  • The Pharmaceutical Journal. Progestogen-only contraceptive pills approved for sale in pharmacies for the first time, 8 July 2021. Pharmaceutical Journal
  • Health Canada Drug Product Database: Min-Ovral 21 (DIN 02042320), Min-Ovral 28 (DIN 02042339), Ovima 21 and 28; Prescription, Marketed; checked 12 November 2026. Health Canada
  • healthdirect Australia: Levlen ED, Schedule 4 (data updated 4 November 2026). healthdirect; PBS item 1394J, levonorgestrel 150 microgram + ethinylestradiol 30 microgram. PBS
  • US FDA, Drugs@FDA (openFDA): Nordette-21, NDA 018668 (approved 10 May 1982), and Nordette-28, NDA 018782, discontinued; Federal Register determination not withdrawn for safety or effectiveness reasons. Checked 12 November 2026.
  • US FDA news release. FDA approves first nonprescription daily oral contraceptive, 13 July 2023. FDA
  • CMS National Average Drug Acquisition Cost (NADAC), 2026 file as of 11 November 2026, effective 21 October 2026: Portia-28, Altavera-28, Marlissa-28, Kurvelo-28, Ayuna-28 and Chateal EQ-28 $0.12154 per tablet; levonorgestrel-ethinyl estradiol 0.15 mg-0.03 mg (NDC 68180-0843, 68462-0672) $0.22773 per tablet. data.medicaid.gov
  • Indian pharmacy listings for Ovral L (Pfizer Ltd, strip of 21, MRP Rs 68.08): Tata 1mg, PharmEasy and Truemeds, read 12 November 2026. Tata 1mg, PharmEasy, Truemeds
  • MHRA press release, 13 February 2026, warning against buying medicines from unregulated online sellers. GOV.UK
  • US Food and Drug Administration. Personal Importation. FDA

This page is information, not medical advice. Start Ovral L only after a doctor, nurse or pharmacist has checked your blood pressure and your blood clot risk.

Frequently asked questions

What is Ovral L?

Ovral L is a combined birth control pill made in India by Pfizer Limited. Each tablet contains levonorgestrel 0.15 mg and ethinylestradiol 0.03 mg, and every tablet in the 21 tablet strip is the same. The Indian label lists it for preventing pregnancy and also for painful periods, abnormal uterine bleeding and endometriosis.

Is Ovral L the same as Microgynon 30 or US generics like Portia?

It contains the same stated doses (150 micrograms of levonorgestrel and 30 micrograms of ethinylestradiol) as Microgynon 30 in the UK, Min-Ovral in Canada and US generics such as Portia, Altavera and Kurvelo. We know of no published study comparing the Indian tablet with those products, so treat them as the same doses rather than proven identical products. The Indian strip has 21 tablets and no inactive tablets; US packs have 28.

How much does Ovral L cost per cycle?

As of November 2026, 42 tablets (two cycles) cost $13 ($6.50 a cycle) and 63 tablets (three cycles) cost $18 ($6.00 a cycle), before shipping. Shipping is $25 under $149 and free from $149. In the US, pharmacies pay about $0.12 to $0.23 a tablet for generics (NADAC), and in the UK the NHS supplies the pill free, so a local supply is usually cheaper. The pack selector shows the current price.

How do I take Ovral L?

Take one tablet at about the same time every day for 21 days, then take none for 7 days, during which a withdrawal bleed usually starts. Begin the next strip after the 7 days. The Indian label says to begin the first strip by day 5 of your period; we suggest starting on day 1, or using condoms for the first 7 days if you start later.

What if I miss an Ovral L tablet?

If you are less than 12 hours late, take it as soon as you remember and carry on as normal. If you are more than 12 hours late or have missed two or more, take the last missed tablet now, carry on as normal and use condoms or another non-hormonal method for 7 days. If fewer than 7 tablets remain in the strip, start the next strip without a break. Ask a pharmacist about emergency contraception if you had sex in the days before.

Can Ovral L be used for painful or heavy periods or endometriosis?

The Indian label lists primary dysmenorrhoea and abnormal uterine bleeding at the normal contraceptive dose, and endometriosis as two tablets daily continuously. These need a diagnosis and a doctor's supervision; do not use the endometriosis dose on your own. The US label covers pregnancy prevention only.

What are the common side effects of Ovral L?

Headache and breakthrough bleeding or spotting are very common in the Indian label. Nausea, breast tenderness, mood changes, dizziness, acne, fluid retention and weight change are common. In two US trials of this dose, bleeding between periods occurred in about 13% of cycles, and about 3% of women stopped because of it. Irregular bleeding is most common in the first three months.

Does Ovral L cause blood clots?

All combined pills raise the risk of blood clots. The Indian label gives about 20 to 40 venous clots per 100,000 women-years for pills with under 50 micrograms of ethinylestradiol, against 5 to 10 in non-users and about 60 in pregnancy. The UK Microgynon 30 label says levonorgestrel pills are associated with the lowest risk of venous clots among combined pills. Leg pain or swelling, chest pain or sudden breathlessness need emergency help.

Who should not take Ovral L?

Do not take it if you have had a blood clot, stroke or heart attack, have a clotting disorder, migraine with aura, uncontrolled high blood pressure, diabetes with blood vessel damage, breast cancer, liver tumours or active liver disease, undiagnosed vaginal bleeding, or are pregnant. The US label also rules it out for women over 35 who smoke. If you are over 35 and smoke, do not buy it from us.

Do I need a prescription for Ovral L?

This pill combination is prescription only in the US, UK, Canada and Australia, and Indian pharmacies such as Tata 1mg and Truemeds mark Ovral L as prescription required. The Indian pack is not registered with the FDA, MHRA, TGA or Health Canada, and the FDA says personal importation of unapproved drugs is illegal in most circumstances. Have your blood pressure and clot risk checked before you start.

How long does delivery take?

Delivery takes 7 to 14 business days to the US, UK, Australia and Canada, in plain packaging with tracking. Shipping costs $25 on orders under $149 and is free from $149. Reorder well before your last strip runs out, and never use our delivery for emergency contraception.

Guide to Female Infertility & Ovulation InductionHow clomiphene triggers ovulation in PCOS and anovulatory women, success rates, dosing protocol, how to time sex around Clomid, and what to do if it does not work.

Related articles

Customer Reviews

No reviews yet. Bought Ovral L? Tell other buyers how it went.